2026 Shanghai CBE R&D Tech Recap: Biotech Innovation, AI Empowerment & Targeted Delivery Define New Era

May 14, 2026 – The 30th China Beauty Expo (CBE) Shanghai has concluded successfully. The R&D and raw material pavilions (Halls N4/N5) gathered leading domestic and international research institutions and brand labs, including Quanli, Nosbel, COSMAX, Bloomage Bio, G2B, Pechoin R&D Center, and Proya Lab. They collectively unveiled five core technology achievements: synthetic biology-derived ingredients, AI-driven full-link R&D, targeted delivery systems, 3D skin models, and visualized efficacy evaluation — marking China’s cosmetics R&D transition from “following global trends” to “independent innovation, evidence-based efficacy, and personalized customization”.

1. Independently Developed Biotech Ingredients: Synthetic Biology + Fermentation + Chinese Botanicals

Domestic raw material innovation took center stage, prioritizing self-sufficiency, high efficacy, safety, and sustainability.

• Synthetic biology recombinant proteins: Bloomage Bio and G2B launched recombinant collagen (99.9% purity), type III collagen, and human-like elastin — 50% higher water solubility, 30% lower cost, replacing animal-derived collagen in anti-aging, soothing, and medical dressing applications.
• Microbial fermentation actives: Quanli and Nosbel presented fermented peptides, lactobacillus metabolites, ganoderma polysaccharides, and cordycepin — 定向 fermentation boosted antioxidant and anti-inflammatory efficacy by 2–3x, balancing mildness and potency.
• Chinese botanical cell culture: Forest Cabin and Inoherb showcased alpine rose cells, dendrobium callus tissue, and ginseng stem cells — plant tissue culture enables land-free, pesticide-free, stable 成分 production, powering “oil-based brightening” and barrier repair with cultural storytelling + tech moats.
• Green sustainable raw materials: Sugarcane-derived glycerin, trehalose, plant squalane, and fermented hyaluronic acid were widely displayed, with 40–60% lower carbon footprints, complying with EU CPNP and China’s dual-carbon goals.

2. AI-Driven Full-Link R&D: From Target Screening to Formulation in 72 Hours

AI has evolved from a buzzword to a daily R&D tool, revolutionizing workflows.

• AI molecular design & target screening: COSMAX and Proya Lab launched AI active ingredient prediction systems — deep learning identifies anti-aging, brightening, and anti-inflammatory targets, boosting screening efficiency 100x and cutting cycles to 1 week, yielding proprietary peptides and botanical extracts.
• AI formulation optimization: Nosbel and Bavi displayed AI formula generators — input efficacy, sensory, and cost parameters to generate 50 optimal formulas in 10 minutes, auto-matching ingredient compatibility and stability, raising sample success rates to 90% and shortening R&D by 70%.
• AI skin diagnosis & customization: FutureLab and COSMAX maXpace unveiled 3D skin scanners + AI custom manufacturing devices — 30-second analysis of texture, spots, wrinkles, and microbiome, real-time personalized formula creation + on-site production, enabling “one person, one formula” with zero-inventory sustainability.
• AI-assisted efficacy testing: In silico simulation of skin penetration, antioxidant, and anti-inflammatory effects reduced animal testing by 50%, accelerating launches and aligning with global alternative testing trends.

3. Targeted Delivery Technologies: Nano-Encapsulation, Supramolecules & Extracellular Vesicles

Raw material competition entered a “delivery & bioavailability” phase, focusing on effective ingredient penetration, retention, and safety.

• Nano-emulsification & liposomes: COSMAX introduced 1 quadrillion-level nano-emulsification — high-pressure homogenization produces 10–50nm ultra-small droplets, maintaining lightweight texture at 30% oil phase, boosting skin penetration by 80% for moisturizing, soothing, and anti-aging serums.
• Supramolecular encapsulation & slow release: Bloomage Bio and Quanli presented cyclodextrin and hyaluronic acid supramolecular complexes — stabilizing retinol, VC, and niacinamide, 10x longer stability and 24-hour sustained release, reducing irritation.
• Extracellular vesicles (exosomes): Multiple labs launched plant/stem cell exosomes (30–150nm), naturally penetrating the skin barrier and targeting the dermis for powerful repair and anti-aging, emerging as a premium anti-aging staple.
• Microneedle & transdermal tech: Soluble hyaluronic acid microneedles and polymer microneedle patches painlessly penetrate the stratum corneum for direct active delivery, 3–5x higher absorption, enabling at-home skincare solutions.

4. Innovative Formulations & Processes: Minimalist High-Efficacy + Multi-Function + Mild Safety

Formulation innovation focused on efficacy, mildness, convenience, and sensory experience, breaking traditional limitations.

• Waterless & solid skincare: Waterless serum powders, solid masks, and lyophilized serum blocks — preservative-free, emulsifier-free, full activity retention, reconstitutable with water, lightweight and eco-friendly, aligning with clean beauty trends.
• Emulsion & cream innovations: “Water-oil-water” triple emulsification and lipid bilayer biomimetic skin — mimicking the skin barrier for dual moisturizing + repair, suitable for sensitive skin.
• Skincare-infused color cosmetics: Skin-nourishing foundations, soothing lipsticks, and calming eyeshadows infused with recombinant collagen, panthenol, and asiaticoside — combining makeup and skincare, mild and non-comedogenic.
• Low-temperature emulsification & green processes: Emulsification at 40°C without high heat preserves heat-sensitive actives, 50% lower energy use and reduced carbon emissions, supporting sustainable manufacturing.

5. Safety & Efficacy Evaluation: Visualization + Alternative Models + Clinical Evidence

Efficacy is no longer promotional but verifiable, quantifiable, and perceptible, rebuilding consumer trust.

• 3D skin model alternative testing: Quanli and Bloomage Bio showcased 3D human skin equivalents — mimicking real skin structure for irritation, sensitization, and efficacy testing, replacing 70% of animal tests with human-relevant data.
• Visualized efficacy instrumentation: VISIA scanners, TEWL meters, and melanin analyzers quantify brightening, anti-aging, and repair effects in real time, making results transparent and ending “myth-based skincare”.
• Standardized human clinical trials: Brands partnered with top tertiary hospital dermatology departments for randomized, double-blind, controlled trials, issuing authoritative clinical reports — traceable, reproducible efficacy data becoming a premium product standard.
• Microbiological barrier & quality control: Proprietary mild preservative systems and multi-pathogen inhibition tech ensure gentleness while strictly controlling microbial, heavy metal, and pesticide residues across the supply chain.

6. Key Trends 2026–2027: Four Core R&D Directions

1. Independent ingredient innovation: Synthetic biology, fermentation, and Chinese botanicals dominate, with self-sufficiency + high efficacy + sustainability as triple moats.
2. Intelligent R&D: AI penetrates the full R&D cycle, with rapid screening, smart formulation, and custom manufacturing becoming industry standards.
3. Precision delivery: Nano, supramolecular, and exosome technologies expand, boosting absorption and reducing irritation.
4. Evidence-based efficacy: 3D models + instrumentation + clinical reports drive data-driven trust rebuilding.

Closing Note

2026 Shanghai CBE was not just a tech showcase but a powerful display of China’s cosmetics R&D prowess. From raw materials to formulations, AI to biotech, lab to mass production, Chinese cosmetics R&D has achieved global competitiveness. In the next two years, tech-driven brands delivering high efficacy, safety, sustainability, and differentiation will lead industry growth.